Ultragenyx Pharmaceutical reported $2.13B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.53B 199M Aug/2026
Alnylam Pharmaceuticals USD 40.19B 3.96B Jun/2026
BioCryst Pharmaceuticals USD 1.9B 643M Aug/2026
BioMarin Pharmaceutical USD 11.71B 651M Aug/2026
Immunic USD 64M 23M Dec/2025
Insmed USD 19.68B 3.43B Aug/2026
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
Karyopharm Therapeutics USD 221M 95M Aug/2026
Kyowa Hakko Kirin JPY 1.28T 76.58B Aug/2026
MacroGenics USD 184M 82M Mar/2026
Neurocrine Biosciences USD 16.95B 3.7B Jun/2026
Regeneron Pharmaceuticals USD 65.37B 16.31B Jun/2026
Sarepta Therapeutics USD 1.5B 402M Aug/2026
Ultragenyx Pharmaceutical USD 2.12B 1.16B Aug/2026
Vertex Pharmaceuticals USD 121.59B 4.48B Aug/2026